Rog, David

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet

Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling

Cited by 942

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

Rog, D. J., Nurmikko, T. J., Friede, T., & Young, C. A. (2005) · Neurology

Cannabis and Cannabinoid ResearchMultiple Sclerosis Research Studies

Cited by 679

Oromucosal Δ9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: An uncontrolled, open-label, 2-year extension trial

ROG, D., NURMIKKO, T., & YOUNG, C. (2007) · Clinical Therapeutics

Cannabis and Cannabinoid ResearchPain Mechanisms and Treatments

Cited by 187

Use of Coping Strategies in Multiple Sclerosis: Association with Demographic and Disease-Related Characteristics ✰

Holland, D. P., Schlüter, D. K., Young, C. A., Mills, R. J., Rog, D. J., Ford, H. L., & Orchard, K. (2019) · Multiple Sclerosis and Related Disorders

Multiple Sclerosis Research StudiesCancer survivorship and care

Cited by 38

The four self-efficacy trajectories among people with multiple sclerosis: clinical associations and implications

Young, C. A., Mills, R., Langdon, D., Sharrack, B., Majeed, T., Kalra, S., Footitt, D., Rog, D., Harrower, T., Nicholas, R., et al. (2022) · Journal of the Neurological Sciences

Multiple Sclerosis Research StudiesCancer survivorship and care

Cited by 10